| Benita Anita Hernandez, | |
|
5022 Avenue Q, Lubbock, TX 79412-2700 | |
| (806) 762-3597 | |
| (806) 762-8816 |
| Full Name | Benita Anita Hernandez |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 5022 Avenue Q, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134732407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 848911 (Texas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 1012439 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umc Physicians | 9830003631 | 114 |
News Archive
Patients with coronary artery disease and low levels of "good cholesterol - or high-density lipoprotein - who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research.
The proper role of health insurance should be to finance necessary and expensive medical services without the patient incurring devastating financial consequences. Over the last decade, however, Americans have come to expect their health insurance to subsidize the consumption of all medical care. ... This shift in expectation has meant that health insurance stands out as entirely different from all other types of insurance. Ask yourself: Would you use automobile insurance to buy gasoline? Would you use homeowner insurance to finance painting your house? This wrongheaded view has played an important role in contributing to rapidly rising health care costs (George P. Shultz, Scott W. Atlas and John F. Cogan, 1/5).
Researchers at the Hong Kong University of Science and Technology have found a way to stimulate the growth of axons, which may spell the dawn of a new beginning on chronic SCI treatments.
Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first Tumor Paint product candidate, BLZ-100. The study, titled "A Phase I Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects with Skin Cancer," will enroll up to 30 patients with basal cell carcinoma, squamous cell carcinoma, or amelanotic melanoma.
› Verified 9 days ago
| Entity Name | Umc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669418547 PECOS PAC ID: 9830003631 Enrollment ID: O20040406001716 |
News Archive
Patients with coronary artery disease and low levels of "good cholesterol - or high-density lipoprotein - who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research.
The proper role of health insurance should be to finance necessary and expensive medical services without the patient incurring devastating financial consequences. Over the last decade, however, Americans have come to expect their health insurance to subsidize the consumption of all medical care. ... This shift in expectation has meant that health insurance stands out as entirely different from all other types of insurance. Ask yourself: Would you use automobile insurance to buy gasoline? Would you use homeowner insurance to finance painting your house? This wrongheaded view has played an important role in contributing to rapidly rising health care costs (George P. Shultz, Scott W. Atlas and John F. Cogan, 1/5).
Researchers at the Hong Kong University of Science and Technology have found a way to stimulate the growth of axons, which may spell the dawn of a new beginning on chronic SCI treatments.
Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first Tumor Paint product candidate, BLZ-100. The study, titled "A Phase I Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects with Skin Cancer," will enroll up to 30 patients with basal cell carcinoma, squamous cell carcinoma, or amelanotic melanoma.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benita Anita Hernandez, 5219 City Bank Pkwy Ste 35, Lubbock, TX 79407-3545 Ph: (806) 761-0333 | Benita Anita Hernandez, 5022 Avenue Q, Lubbock, TX 79412-2700 Ph: (806) 762-3597 |
News Archive
Patients with coronary artery disease and low levels of "good cholesterol - or high-density lipoprotein - who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research.
The proper role of health insurance should be to finance necessary and expensive medical services without the patient incurring devastating financial consequences. Over the last decade, however, Americans have come to expect their health insurance to subsidize the consumption of all medical care. ... This shift in expectation has meant that health insurance stands out as entirely different from all other types of insurance. Ask yourself: Would you use automobile insurance to buy gasoline? Would you use homeowner insurance to finance painting your house? This wrongheaded view has played an important role in contributing to rapidly rising health care costs (George P. Shultz, Scott W. Atlas and John F. Cogan, 1/5).
Researchers at the Hong Kong University of Science and Technology have found a way to stimulate the growth of axons, which may spell the dawn of a new beginning on chronic SCI treatments.
Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first Tumor Paint product candidate, BLZ-100. The study, titled "A Phase I Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects with Skin Cancer," will enroll up to 30 patients with basal cell carcinoma, squamous cell carcinoma, or amelanotic melanoma.
› Verified 9 days ago
Kelli Chari Tyler Hayes, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7008 Indiana Ave, Ste A, Lubbock, TX 79413 Phone: 806-698-8088 Fax: 806-698-8588 | |
Gay Ann Tibbets, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1902 50th St, Lubbock, TX 79412 Phone: 806-771-1386 Fax: 806-771-1388 | |
Kevin Cole, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St Ste 440, Lubbock, TX 79415 Phone: 806-761-0535 Fax: 806-761-0534 | |
Emily Flathouse, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7301 Milwaukee Avenue, Lubbock, TX 79424 Phone: 806-761-0464 Fax: 806-698-6710 | |
Malory Shanks, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6104 Avenue Q South Dr, Lubbock, TX 79412 Phone: 806-472-3400 | |
Mrs. Jessica D Ann Sisneros, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3506 21st St Ste 507, Lubbock, TX 79410 Phone: 806-725-4805 Fax: 806-723-4815 | |
Renee Naomi Livesay, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8504 Kenosha Dr, Lubbock, TX 79423 Phone: 806-773-5880 |